Prothena Corp. Plc (PRTA)

12.30
NASDAQ : Health Technology
Prev Close 13.30
Day Low/High 12.25 / 13.28
52 Wk Low/High 8.63 / 44.75
Avg Volume 400.30K
Exchange NASDAQ
Shares Outstanding 39.86M
Market Cap 530.19M
EPS -3.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
New Lifetime High Reached By Prothena (PRTA)

New Lifetime High Reached By Prothena (PRTA)

Trade-Ideas LLC identified Prothena (PRTA) as a new lifetime high candidate

10 Best Biotech Stocks in the NASDAQ

10 Best Biotech Stocks in the NASDAQ

The biotech sector has been one of the fastest growing sectors through June 30, 2015. Here are the 10 best biotech stocks this year.

Perilous Reversal Stock: Prothena (PRTA)

Perilous Reversal Stock: Prothena (PRTA)

Trade-Ideas LLC identified Prothena (PRTA) as a "perilous reversal" (up big yesterday but down big today) candidate

Strong On High Volume: Prothena (PRTA)

Strong On High Volume: Prothena (PRTA)

Trade-Ideas LLC identified Prothena (PRTA) as a strong on high relative volume candidate

Playing Biotechs with the House's Money

Playing Biotechs with the House's Money

Here's how to lock in gains on risky small-cap biotechnology stocks.

Today's Weak On High Volume Stock: Prothena (PRTA)

Today's Weak On High Volume Stock: Prothena (PRTA)

Trade-Ideas LLC identified Prothena (PRTA) as a weak on high relative volume candidate

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.

Prothena (PRTA) In A Perilous Reversal

Prothena (PRTA) In A Perilous Reversal

Trade-Ideas LLC identified Prothena (PRTA) as a "perilous reversal" (up big yesterday but down big today) candidate

'Mad Money' Lightning Round: Sell, Sell, Sell Seadrill but Keep Six Flags

'Mad Money' Lightning Round: Sell, Sell, Sell Seadrill but Keep Six Flags

Cramer says Prothena is a winner, Cigna can go higher but Chesapeake Energy is not a favorite.

Jim Cramer's 'Mad Money' Recap: How to Profit From a Hideous Day for Stocks

Jim Cramer's 'Mad Money' Recap: How to Profit From a Hideous Day for Stocks

Once things settle down, start picking through the rubble for the stocks that went lower but shouldn't have, Cramer says.

Prothena (PRTA) Stock Declines Today on Pricing of Secondary Offering

Prothena (PRTA) Stock Declines Today on Pricing of Secondary Offering

Prothena (PRTA) shares are falling following secondary public offering.

Heavy Early Morning Activity On Prothena (PRTA)

Heavy Early Morning Activity On Prothena (PRTA)

Trade-Ideas LLC identified Prothena (PRTA) as a pre-market mover with heavy volume candidate

Watch the Dollar and Supply

The weak dollar was the breeze that pushed the market higher.

Backing Away From Biotechs

This sector could see some real damage.

TheStreet Quant Rating: D (Sell)